Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Science (New York, N.Y.)|December 22, 2005
Metagenomics to paleogenomics: large-scale sequencing of mammoth DNAHendrik N Poinar, Carsten Schwarz, Ji Qi, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2019
Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosisPavel Drevinek, Tacjana Pressler, Marco Cipolli, et al.Nature|September 2, 2011
Antibiotic resistance is ancientVanessa M D'Costa, Christine E King, Lindsay Kalan, et al.Frontiers in Pharmacology|November 29, 2023
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaireJochen G Mainz, Anton Barucha, Pu Huang, et al.Mycopathologia|November 4, 2017
Organization of Patient Management and Fungal Epidemiology in Cystic FibrosisCarsten Schwarz, Jean-Philippe Bouchara, Walter Buzina, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 10, 2018
Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosisCarsten Schwarz, Claudia Brandt, Volker Melichar, et al.Journal of Fungi (Basel, Switzerland)|February 25, 2023
Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis PatientsLeire Martin-Souto, Aitziber Antoran, Maialen Areitio, et al.Emerging Microbes & Infections|April 14, 2022
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitroMichaela Lackner, Annika Rössler, André Volland, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 10, 2019
GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN)Silke van Koningsbruggen-Rietschel, Katja Conrath, Rainald Fischer, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 22, 2023
Every CFTR variant counts - Target-capture based next-generation-sequencing for molecular diagnosis in the German CF RegistrySimone Ahting, Lutz Nährlich, Inka Held, et al.Pageof 9